# The prognostic significance of lymph nodes in patients with pT1c33N0M0 non-small cell lung cancer: a retrospective study

**Authors:** Wei Yang, Luyi Wang

PMC · DOI: 10.7717/peerj.16866 · PeerJ · 2024-01-31

## TL;DR

This study shows that the number of lymph nodes at the N1 station affects the prognosis of early-stage non-small cell lung cancer patients.

## Contribution

The study identifies three or more N1 lymph nodes as a favorable prognostic indicator in pT1c33N0M0 NSCLC patients.

## Key findings

- Lymph nodes are an independent prognostic factor for pT1c33N0M0 NSCLC patients.
- Patients with ≥3 N1 lymph nodes have better survival outcomes than those with <3 nodes.
- ROC analysis identified 2.7 as the optimal N1 node threshold for prognosis prediction.

## Abstract

The objective of this study was to appraise the prognostic impact of lymph nodes in patients diagnosed with pT1c33N0M0 non-small cell lung cancer (NSCLC) and to delve into the prognostic significance of lymph nodes located at the N1 lymph node station in this patient cohort.

A retrospective analysis of clinical data was conducted for 255 patients diagnosed with pT1c33N0M0 NSCLC. Lymph nodes were tabulated and categorized into three groups (0–10 nodes, 11–16 nodes, >16 nodes). Clinical data among these three groups of pT1c33N0M0 NSCLC patients were compared. We conducted both univariate and multivariate analyses to pinpoint the factors that impact the prognosis of patients with pT1c33N0M0 non-small cell lung cancer (NSCLC). Additionally, we employed receiver operating characteristic (ROC) curve analysis to pinpoint the optimal lymph node criteria at the N1 station for prognostic prediction in pT1c33N0M0 NSCLC patients.

Within the cohort of 255 individuals afflicted with pT1c33N0M0 non-small cell lung cancer (NSCLC), a comprehensive tally of 3,902 lymph nodes was diligently established, yielding an average of 15.3 nodes for each patient. Multivariate analysis demonstrated that tumor size, T stage, and lymph nodes were independent factors significantly impacting the prognosis of pT1c33N0M0 NSCLC patients (P < 0.05). ROC curve analysis revealed an area under the curve of 0.6982 for predicting prognosis using N1 station in pT1c33N0M0 NSCLC patients. The maximum Youden index was observed at an N1 station of 2.7 nodes. Patients with N1 station ≥ three nodes had significantly better prognoses compared to those with < 3 nodes (both P < 0.05).

Lymph nodes serve as an independent prognostic factor for pT1c33N0M0 NSCLC patients. Detecting at least three or more lymph nodes at the N1 station is associated with a more favourable prognosis in pT1c33N0M0 NSCLC patients.

## Linked entities

- **Diseases:** non-small cell lung cancer (MONDO:0005233), NSCLC (MONDO:0005233)

## Full-text entities

- **Diseases:** tumor (MESH:D009369), NSCLC (MESH:D002289)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10838084/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10838084/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC10838084/full.md

---
Source: https://tomesphere.com/paper/PMC10838084